Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CBL137 IV
i
Other names:
CBL137 IV, CBL0137 IV, CBLC137, CBLC 137, CBLC-137, CBL 0137
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Incuron, Statera BioPharma
Drug class:
NF-κB inhibitor, p53 stimulant, SSRP1 inhibitor
Related drugs:
‹
SBI-756 (2)
BAY-61-3606 (1)
DC-1-192 (1)
EC-70124 (1)
sodium metaarsenite (1)
SBI-726 (1)
omtriptolide (1)
CBL0102 (1)
ascorbic acid/menadione (0)
Bay11-7082 (0)
antroquinonol (0)
KLTi (0)
SR13668 (0)
efprezimod alfa (0)
bezisterim (0)
iMX-110 (0)
ETS2101 (0)
ACT001 (0)
PBI-05204 (0)
piceatannol (0)
BTX-A51 (1)
COTI-2 (1)
thioureidobutyronitrile (1)
Ad-p53 gene therapy (0)
rAd-p53 Gene Therapy (0)
INGN 225 (0)
recombinant human adenovirus type 5 (0)
SGT-53 (0)
p53MVA (0)
OBP-702 (0)
SBI-756 (2)
BAY-61-3606 (1)
DC-1-192 (1)
EC-70124 (1)
sodium metaarsenite (1)
SBI-726 (1)
omtriptolide (1)
CBL0102 (1)
ascorbic acid/menadione (0)
Bay11-7082 (0)
antroquinonol (0)
KLTi (0)
SR13668 (0)
efprezimod alfa (0)
bezisterim (0)
iMX-110 (0)
ETS2101 (0)
ACT001 (0)
PBI-05204 (0)
piceatannol (0)
BTX-A51 (1)
COTI-2 (1)
thioureidobutyronitrile (1)
Ad-p53 gene therapy (0)
rAd-p53 Gene Therapy (0)
INGN 225 (0)
recombinant human adenovirus type 5 (0)
SGT-53 (0)
p53MVA (0)
OBP-702 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login